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Studies excluded after full-text review: reasons for exclusion
Forty-seven studies were excluded after the full text analysis: nine because included ≤50 patients in DPP4-i + SU group [1] [2] [3] [4] [5] [6] [7] [8] [9] , seven because they were not RCTs, [10] [11] [12] [13] [14] [15] [16] one because there was no placebo group, [17] five because the patients were not treated with DPP4-i + SU, [18] [19] [20] [21] [22] three because they were extension studies, [23] [24] [25] two because they were subanalyses or post-hoc analyses, [26, 27] 15 because they were pooled analyses without new data, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] two because they were not assessable, [43, 44] and three because they did not report data on hypoglycaemia in patients treated with DPP4-i + SU and, after having e-mailed authors or study contacts, we did not received the requested data. [45] [46] [47] . Statistical heterogeneity among studies was evaluated with the Q statistic (p<0.10 considered significant), and the proportion of total variation contributed by between-study variance was estimated by using the I 2 index. The risk of bias for each included study is presented as different coloured circles: green represents a low risk of bias, and yellow an unclear risk of bias.
eFigure 2. Forest plot of the risk of hypoglycaemia in patients treated with DPP4-i + SU in comparison with those treated with placebo + SU including RCTs with a wellbalanced sex ratio among groups.
Risk ratios (RR) calculated for individual randomised controlled trials (RCTs) with 95% confidence intervals (CI) are presented. Arrows indicate the CI exceeding the limits of the graph. Pooled RR is also presented (black diamond). Statistical heterogeneity among studies was evaluated with the Q statistic (p<0.10 considered significant), and the proportion of total variation contributed by between-study variance was estimated by using the I 2 index. The risk of bias for each included study is presented as different coloured circles: green represents a low risk of bias, red a high risk of bias, and yellow an unclear risk of bias. Pooled RR is also presented (black diamond). Statistical heterogeneity among studies was evaluated with the Q statistic (p<0.10 considered significant), and the proportion of total variation contributed by between-study variance was estimated by using the I 2 index. The risk of bias for each study included is presented as different coloured circles: green represents a low risk of bias, red a high risk of bias, and yellow an unclear risk of bias.
Risk of bias assessment (Cochrane Collaboration tool) of included studies.
Barnett et al. [ A randomization list was produced using a health authority-inspected and validated system that automates the random assignment of treatment groups to randomization numbers in the specified ratio.
Allocation concealment (selection bias) Low risk
A randomization list was produced using a health authority-inspected and validated system that automates the random assignment of treatment groups to randomization numbers in the specified ratio. Dynamic randomization was used to adjust for demographic differences between the treatment groups. A maximum difference of two subjects was permitted between the treatment groups at each study center (29 centers), and the six dose levels of glimepiride were used as an adjustment factor.
Allocation concealment (selection bias) Low risk Dynamic randomization was used to adjust for demographic differences between the treatment groups.
Blinding of participants and personnel (performance bias)
Low risk Double-blind placebo-controlled study; dose adjustments to the treatment were not allowed at anytime after randomization.
Blinding of outcome assessment (detection bias) Low risk
Patients were required to record the event and associated information such as glucose value and time of occurrence in the study diary. Haematology, biochemistry and urinalysis were performed at each scheduled visit. All laboratory assessments were processed at a central testing laboratory to ensure consistency.
Incomplete outcome data (attrition bias)
Low risk The drop out rate was well balanced among groups Selective reporting (reporting bias)
High risk Only symptomatic hypoglycaemia was included Other bias Low risk None detected 13 Lewin et al. [ 
